Free Trial

Cwm LLC Acquires 70,352 Shares of Tempus AI, Inc. (NASDAQ:TEM)

Tempus AI logo with Medical background

CWM LLC boosted its position in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) by 82.6% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 155,536 shares of the company's stock after purchasing an additional 70,352 shares during the period. CWM LLC owned 0.09% of Tempus AI worth $7,503,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Franklin Resources Inc. grew its holdings in shares of Tempus AI by 240.5% during the 4th quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company's stock valued at $93,251,000 after acquiring an additional 1,950,862 shares in the last quarter. JPMorgan Chase & Co. grew its holdings in shares of Tempus AI by 86,947.2% during the 4th quarter. JPMorgan Chase & Co. now owns 1,653,896 shares of the company's stock valued at $55,836,000 after acquiring an additional 1,651,996 shares in the last quarter. Norges Bank purchased a new position in shares of Tempus AI during the 4th quarter valued at $34,681,000. Sumitomo Mitsui Trust Group Inc. grew its holdings in shares of Tempus AI by 31.4% during the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company's stock valued at $205,284,000 after acquiring an additional 1,016,384 shares in the last quarter. Finally, Mariner LLC purchased a new position in shares of Tempus AI during the 4th quarter valued at $31,187,000. 24.22% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

TEM has been the subject of a number of recent research reports. Piper Sandler upped their price objective on shares of Tempus AI from $55.00 to $70.00 and gave the stock a "neutral" rating in a report on Thursday, May 15th. Needham & Company LLC reiterated a "buy" rating and issued a $70.00 price objective on shares of Tempus AI in a report on Wednesday, May 7th. Bank of America upped their price objective on shares of Tempus AI from $68.00 to $70.00 and gave the stock a "neutral" rating in a report on Wednesday, June 25th. Guggenheim upped their price objective on shares of Tempus AI from $65.00 to $75.00 and gave the stock a "buy" rating in a report on Monday, June 30th. Finally, Morgan Stanley upped their price target on shares of Tempus AI from $60.00 to $65.00 and gave the company an "overweight" rating in a report on Friday, May 9th. Six analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. According to MarketBeat.com, Tempus AI presently has a consensus rating of "Moderate Buy" and a consensus target price of $65.09.

Check Out Our Latest Analysis on Tempus AI

Insider Buying and Selling at Tempus AI

In other Tempus AI news, Director Jennifer A. Doudna sold 625 shares of Tempus AI stock in a transaction dated Tuesday, July 1st. The shares were sold at an average price of $62.52, for a total value of $39,075.00. Following the completion of the sale, the director owned 26,554 shares in the company, valued at $1,660,156.08. The trade was a 2.30% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Erik Phelps sold 51,317 shares of Tempus AI stock in a transaction dated Monday, June 16th. The stock was sold at an average price of $72.56, for a total transaction of $3,723,561.52. Following the completion of the sale, the executive vice president owned 97,779 shares of the company's stock, valued at $7,094,844.24. This trade represents a 34.42% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 612,522 shares of company stock worth $41,600,238 in the last ninety days. Insiders own 27.60% of the company's stock.

Tempus AI Trading Down 0.4%

NASDAQ TEM traded down $0.23 during trading hours on Friday, hitting $60.43. The company's stock had a trading volume of 3,782,136 shares, compared to its average volume of 7,654,961. Tempus AI, Inc. has a twelve month low of $31.36 and a twelve month high of $91.45. The company has a quick ratio of 1.56, a current ratio of 1.71 and a debt-to-equity ratio of 2.45. The stock has a fifty day moving average of $63.06 and a 200 day moving average of $55.46. The firm has a market capitalization of $10.46 billion and a P/E ratio of -7.78.

Tempus AI (NASDAQ:TEM - Get Free Report) last issued its quarterly earnings results on Tuesday, May 6th. The company reported ($0.24) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.27) by $0.03. Tempus AI had a negative net margin of 88.27% and a negative return on equity of 533.21%. The firm had revenue of $255.74 million for the quarter, compared to analyst estimates of $248.13 million. Tempus AI's revenue was up 75.4% compared to the same quarter last year. Equities research analysts forecast that Tempus AI, Inc. will post -6.15 earnings per share for the current fiscal year.

Tempus AI Company Profile

(Free Report)

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

See Also

Institutional Ownership by Quarter for Tempus AI (NASDAQ:TEM)

Should You Invest $1,000 in Tempus AI Right Now?

Before you consider Tempus AI, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.

While Tempus AI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters
This Strategy Beat the S&P—And Most Investors Ignore It
NVDA Greenlight: China Sales Spark 50% Rally Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines